Close

BIO's Comments on Proposed PTO Rules Change to Post-Grant Reviews

Comments of BIO on the United States Patent and Trademark Office’s proposed revisions to the standard for construing disputed claim terms in inter partes reviews, post-grant...

BIO Recommendations for Tax Reform 2.0 Package

As the Ways and Means Committee begins to develop new tax legislation, it is imperative that they include policies to incentivize, or at a minimum remove obstacles that impede, the emerging biotechnology companies that are conducting life-changing and life-saving innovation.

BIO Announces Programming Focused on Biobased Markets and Food for the 2018 World Congress in July

The Biotechnology Innovation Organization (BIO) today announced two programming tracks focused on biobased markets and specialty food ingredients, flavors and fragrances at the 2018 World Congress on Industrial Biotechnology. Programming around these topics will take place Tuesday, July 17, with four sessions for each of the two tracks.  

BIO Comments on USDA-AMS National Bioengineered Food Disclosure Standard

The Biotechnology Innovation Organization (BIO) has submitted comments to USDA’s Agricultural Marketing Service (USDA-AMS) on its proposed rule for the National Bioengineered Food Disclosure Standard.

BIO Comments on USDA-AMS National Bioengineered Food Disclosure Standard

RE: Proposed Rule- National Bioengineered Food Disclosure Standard- Doc. No. AMS-TM-17-0050 83; Fed. Reg. 19860 (May 4, 2018)

BIO Statement on the Senate Passage of the 2018 Farm Bill

Washington, D.C. (June 28, 2018) – The following statement may be attributed to Brent Erickson, Biotechnology Innovation Organization (BIO) Executive Vice President, Industrial and Environmental section, in response to the Senate passage of the 2018 Farm Bill:

BIO Announces Plenary Sessions at the 2018 World Congress in July

The Biotechnology Innovation Organization (BIO) today released the list of speakers for plenary programs at the 2018 BIO World Congress on Industrial Biotechnology. The programs will feature executives and experts from the biofuels, biobased products, and agricultural industries who will discuss technologies revolutionizing industrial biotechnology, the evolution of biobased consumer products and the future of the biobased economy. The world’s largest conference on industrial biotechnology and partnering event will be held July 16-19, 2018 at the Pennsylvania Convention Center in Philadelphia.

BIO Applauds SEC for Providing Regulatory Relief to Emerging Biotech Innovators

Today, the Securities and Exchange Commission (SEC) voted to broaden the pool of small companies that benefit from scaled disclosures.  The new definition of “smaller reporting company” (SRC) will reduce compliance burdens on small, innovative biotech companies and enable them to deploy capital and resources in more productive ways, such as investing in life-saving research in the lab or in the clinic.  

BIO Announces GreenTech Investor Sessions at the 2018 World Congress in July

The Biotechnology Innovation Organization (BIO) today announced that nine emerging companies will make formal presentations to investors during GreenTech Investor Sessions at the 2018 BIO World Congress on Industrial Biotechnology. As part of GreenTech Investor Sessions, BIO will also host a panel discussion featuring representatives from investment firms to cover the most recent financial strategies and trends in industrial biotechnology. The world’s largest conference on industrial biotechnology and partnering event will be held July 16-19, 2018 at the Pennsylvania Convention Center in Philadelphia. 

BIO Statement on Proposed 2019 RFS Volumes

Washington, D.C. (June 26, 2018) – Brent Erickson, Executive Vice President of the Biotechnology Innovation Organization’s (BIO) Industrial & Environmental Section, released the following statement today on the proposed Renewable Fuel Standard (RFS) 2019 volumes released by the Environmental Protection Agency (EPA):